NL-OMON32022已完成不适用
A double-blind, randomized, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending oral doses of ASP2905 in healthy young males, including an open-label two-period randomized crossover study to compare the pharmacokinetics under fasted and fed conditions - ASP2905 SAD/food effect study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Healthy young male subject, aged 18-50 years inclusive.
排除标准
- •current clinically significant diseases or conditions or any clinical significant diseases or conditions in medical history.
研究者
相似试验
进行中（未招募）
1 期
A study of UCB0942 in adult patients with highly drug-resistant focal epilepsyEUCTR2014-003330-12-HUCB Biopharma SPR46
进行中（未招募）
1 期
A study of UCB0942 in adult patients with highly drug-resistant focal epilepsyhighly drug-resistant focal epilepsyMedDRA version: 21.1Level: LLTClassification code 10065337Term: Focal epilepsySystem Organ Class: 100000004852EUCTR2014-003330-12-ITCB Biopharma SR55
招募中
1 期
Safety and efficacy of PC945 in combination with other antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis (Opera-T Study)Refractory invasive pulmonary aspergillosis (IPA)MedDRA version: 20.0Level: LLTClassification code 10059259Term: Pulmonary aspergillosisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-004554-32-ATPulmocide Ltd123
已完成
3 期
A double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P, CBD) as add-on therapy in patients with tuberous sclerosis complex who experience inadequately-controlled seizuresNL-OMON47292GW Research Ltd25
尚未招募
2 期
A study to evaluate the efficacy of Eclipta prostrata (L.) L. in the treatment of atopic dermatitis in childreAtopic dermatitsC16.320.850RBR-2fqcbrxFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - USP